{"version":"1.0","type":"rich","provider_name":"Acast","provider_url":"https://acast.com","height":250,"width":700,"html":"<iframe src=\"https://embed.acast.com/$/690348d3076a402ee264ca8a/69035be5bb560dc3067c7f0b?\" frameBorder=\"0\" width=\"700\" height=\"250\"></iframe>","title":"029. Valeant: Drug Prices, Accounting Tactics, and a Pharma Reckoning","description":"<p>All episodes of this podcast are fully researched, written, and edited by our human production team. The final audio is generated using text-to-speech technology to deliver consistent narration quality and listening experience.</p><p>----------------</p><p>The pharmaceutical company that grew through acquisitions and price hikes until questions about its business model sent shares into freefall.</p>","author_name":"Maria W"}